Literature DB >> 7719910

Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

M E Helminen1, R Beach, I Maciver, G Jarosik, E J Hansen, M Leinonen.   

Abstract

The role of Moraxella (Branhamella) catarrhalis as a respiratory tract pathogen is increasingly recognized. We looked at the human immune response against individual outer membrane proteins of M. catarrhalis and against the 81-kDa CopB protein, which has previously been shown to be a target for protective antibodies. Paired serum samples from six elderly patients with pneumonia were tested by Western blot (immunoblot) analysis by using outer membrane vesicles of M. catarrhalis 035E as antigen. All of the six convalescent-phase serum samples reacted with a protein which migrated at the position of the CopB protein and with a high-molecular-weight protein of M. catarrhalis; three serum samples also reacted with a 34-kDa outer membrane protein. Paired serum samples from 18 patients, 10 of which had M. catarrhalis infection on the basis of previous serology results, were tested by enzyme immunoassay (EIA) with the CopB protein and whole cells of M. catarrhalis 035E as antigens. Nine patients showed a significant rise in EIA titer between acute- and convalescent-phase sera when whole bacterial cells were used as antigens. Six (67%) patient samples that were positive by the EIA with the whole-cell antigen were also positive by the EIA with the CopB antigen, and six of nine patient samples negative by the EIA with the whole-cell antigen were also negative by the EIA with the CopB antigen. These results suggest that both the CopB and a high-molecular-weight protein are major targets of the immune response against M. catarrhalis, and further studies with greater amounts of patient materials are needed to elucidate the usefulness of CopB as an antigen in etiologic studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719910      PMCID: PMC170097          DOI: 10.1128/cdli.2.1.35-39.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  39 in total

1.  Isolation of the outer membrane of Branhamella catarrhalis.

Authors:  T F Murphy; M R Loeb
Journal:  Microb Pathog       Date:  1989-03       Impact factor: 3.738

Review 2.  The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen.

Authors:  T F Murphy
Journal:  Pediatr Infect Dis J       Date:  1989-01       Impact factor: 2.129

3.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model.

Authors:  I Maciver; M Unhanand; G H McCracken; E J Hansen
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

5.  A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo.

Authors:  M E Helminen; I Maciver; M Paris; J L Latimer; S L Lumbley; L D Cope; G H McCracken; E J Hansen
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

6.  Acute otitis media and respiratory virus infections.

Authors:  O Ruuskanen; M Arola; A Putto-Laurila; J Mertsola; O Meurman; M K Viljanen; P Halonen
Journal:  Pediatr Infect Dis J       Date:  1989-02       Impact factor: 2.129

Review 7.  Pneumonia due to Moraxella (Branhamella) catarrhalis.

Authors:  P W Wright; R J Wallace
Journal:  Semin Respir Infect       Date:  1989-03

8.  Variability of surface-exposed antigens of different strains of Moraxella catarrhalis.

Authors:  I Jönsson; T Holme; A Krook; M Rahman; M Thorén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

9.  Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children.

Authors:  M Korppi; M L Katila; J Jääskeläinen; M Leinonen
Journal:  Acta Paediatr       Date:  1992-12       Impact factor: 2.299

10.  Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis.

Authors:  K L Klingman; T F Murphy
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

View more
  8 in total

1.  Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein.

Authors:  E Boel; H Bootsma; J de Kruif; M Jansze; K L Klingman; H van Dijk; T Logtenberg
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

2.  Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.

Authors:  C Aebi; L D Cope; J L Latimer; S E Thomas; C A Slaughter; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

Authors:  D Chen; J C McMichael; K R VanDerMeid; D Hahn; T Mininni; J Cowell; J Eldridge
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

Authors:  D Chen; V Barniak; K R VanDerMeid; J C McMichael
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

5.  Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults.

Authors:  Patricia Stutzmann Meier; Nadja Heiniger; Rolf Troller; Christoph Aebi
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 6.  Vaccine targets against Moraxella catarrhalis.

Authors:  Dabin Ren; Michael E Pichichero
Journal:  Expert Opin Ther Targets       Date:  2015-08-26       Impact factor: 6.902

7.  Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E.

Authors:  C Aebi; E R Lafontaine; L D Cope; J L Latimer; S L Lumbley; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 8.  Molecular aspects of Moraxella catarrhalis pathogenesis.

Authors:  Stefan P W de Vries; Hester J Bootsma; John P Hays; Peter W M Hermans
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.